Intravesical electromotive administration of drugs for treatment of superficial bladder cancer: A comparative phase II study

Urology

Volumn 51, Issue 3, 1998, Pages 506-509

  Brausi, M ^a   Campo, B ^a   Pizzocaro, G ^a   Rigatti, P ^a   Parma, A ^a   Mazza, G ^a   Vicini, A ^a   Stephen, R L ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

MITOMYCIN C;

AGED; ARTICLE; BLADDER CARCINOMA; CANCER RECURRENCE; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED STUDY; CYSTITIS; DRUG RESPONSE; ELECTRIC CURRENT; FEMALE; HEMATURIA; HUMAN; INTRAVESICAL DRUG ADMINISTRATION; MALE; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; SUPERFICIAL CANCER; TRANSITIONAL CELL CARCINOMA; TRANSURETHRAL RESECTION;

ADMINISTRATION, INTRAVESICAL; AGED; ANTIBIOTICS, ANTINEOPLASTIC; CARCINOMA, TRANSITIONAL CELL; ELECTRICITY; FEMALE; HUMANS; MALE; MITOMYCIN; NEOPLASM STAGING; URINARY BLADDER NEOPLASMS;

EID: 0032030507     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(97)00625-0     Document Type: Article

References (15)

1. Fitzpatrick JM, West AB, Butler MR, Lane V, O'Flynn JD. Superficial bladder tumors (stages pTA, grades 1 and 2): the importance of recurrence pattern following initial resection. J Urol. 135:1986;920-922.
2. Kurth KH, Denis L, Ten Kate FJW, Sylvester R. Prognostic factors in superficial bladder cancer. Probl Urol. 6:1992;471-483.
3. Thurnell WJ. Therapeutic action of constant current. Proc R Soc Med. 14:1921;41-52.
4. Di Stasi SM, Castagnola M, Vespasiani G, Giannantoni A, Cancrini A, Micali F, Stephen RL. In vitro study of passive vs electromotive mitomycin C diffusion in human bladder wall. Preliminary results J Urol. 151:1994;447A.
5. Huland H, Otto U, Droese M, Kloppel G. Long term mitomycin instillation after transurethral resection of superficial bladder carcinoma: influence on recurrence, progression and survival. J Urol. 132:1994;27-29.
6. Bono AV, Hall RR, Denis L, Lovisolo JA, Sylvester R. Members of the EORTC Genito-Urinary Group. Chemoresection in Ta-T1 bladder cancer. Eur Urol. 29:1996;385-390.
7. Mishina T, Oda K, Murata S, Doe H, Mori Y. Mitomycin C bladder therapy for bladder tumors. J Urol. 114:1975;217-219.
8. Bracken R, Johnson D, Von Eschenbach A, Swanson D. Role of intravesical mitomycin C in the management of superficial bladder tumors. J Urol. 16:1980;11-15.
9. Banga AK, Chien YW. Iontophoretic delivery of drugs: fundamentals, developments and biomedical applications. J Control Release. 7:1988;1-24.
10. Gangarosa LP, Park NH, Wiggins CA, Hill JM. Increased penetration of non-electrolytes into mouse skin during iontophoretic transport (iontohydrokinesis). J Pharm Exp Ther. 212:1980;377-381.
11. Glass JM, Stephen RL, Jacobsen SC. The quantity and distribution of radiolabelled dexamethasone delivered to tissue by iontophoresis. Int J Dermatol. 19:1980;519-525.
12. Petelenz TJ, Buttke JA, Bonds C, Llyod LB, Beck JE, Stephen RL, Iacobsen SC, Rodriguez P. Iontophoresis of dexamethasone; laboratory studies. J Control Release. 7:1992;141-148.
13. Sibalis D, and Rosen S: Electrolytic transdermal delivery of polypeptides. US Patent No. 4,878,892: 5-6.
14. Chien YW, Siddiqui O, Sun Y, Shi WM, Liu JC. Transdermal iontophoretic delivery of therapeutic peptides/proteins. Ann NY Acad Sci. 507:1988;32-51.
15. Hicks RM, Ketterer B, Warren RC. The ultrastructure and chemistry of the luminal plasma membrane of the mammalian urinary bladder: a structure with low permeability to water and ions. Philos Trans R Soc Lond B Biol Sci. 268:1974;23-38.